OXYVIST
Dead / Abandoned — Abandoned — no statement of use filed (as of 03 Jun 2024)
What this means for you
This application is over — abandoned 03 Jun 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90176691
- Mark type
- Stylized text
- Filed
- 12 Sept 2020
- Published for opposition
- 02 Mar 2021
- Abandoned
- 03 Jun 2024
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 005 — Pharmaceuticals: Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Contrast media for in vivo imaging; Contrast media for in-vivo imaging; Contrast media for use with imaging medical equipment
Owner
- Surgisense Corporation, Bethesda, MD, US
- Surgisense Corporation, Bethesda, MD, US
Prosecution history
- 12 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 03 Jun 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Sept 2023 — SOU EXTENSION 5 GRANTED
- 23 Aug 2023 — SOU EXTENSION 5 FILED
- 23 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 28 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Apr 2023 — SOU EXTENSION 4 GRANTED
- 26 Apr 2023 — SOU EXTENSION 4 FILED
- 26 Apr 2023 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2022 — SOU EXTENSION 3 GRANTED
- 20 Oct 2022 — SOU EXTENSION 3 FILED
- 20 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 24 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED